Trials / Completed
CompletedNCT00095043
Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)
A 12-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel Groups, Multicenter Long-Term Safety Study of MK0928 in the Treatment of Elderly Outpatients With Primary Insomnia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 320 (planned)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to study the safety of MK0928 on insomnia in the elderly.
Detailed description
The duration of treatment is 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0928, gaboxadol | |
| DRUG | Comparator: placebo |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2006-06-01
- First posted
- 2004-11-01
- Last updated
- 2016-11-17
Source: ClinicalTrials.gov record NCT00095043. Inclusion in this directory is not an endorsement.